tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market

Tvardi Therapeutics (TVRD) Income Statement

Compare
2,534 Followers

Tvardi Therapeutics Income Statement

Last quarter (Q2 2025), Tvardi Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Tvardi Therapeutics's net income was $4.17M. See Tvardi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.14M$ 20.97M$ 41.87M$ 23.03M$ 135.08M
Gross Profit
$ 6.33M$ 14.54M$ 34.35M$ 21.47M$ 0.00
Operating Expenses
$ 62.11M$ 136.03M$ 121.89M$ 110.56M$ 128.68M
Depreciation and Amortization
$ 192.00K$ 259.00K$ 1.67M$ 1.55M$ 1.01M
EBITDA
$ -62.60M$ -117.65M$ -83.80M$ -86.89M$ 8.73M
Operating Income
$ -55.78M$ -121.50M$ -87.53M$ -89.08M$ 5.38M
Other Income/Expenses
$ -15.48M$ 2.98M$ 2.06M$ 642.00K$ 2.33M
Pretax Income
$ -71.27M$ -118.51M$ -85.47M$ -88.44M$ 7.72M
Net Income
$ -70.87M$ -118.51M$ -85.47M$ -88.44M$ 8.41M
Per Share Metrics
Basic EPS
$ -46.59$ -1.85$ -2.20$ -62.77$ 6.39
Diluted EPS
$ -46.59$ -1.85$ -2.20$ -62.77$ 6.32
Weighted Average Shares Outstanding
1.52M 9.36M 9.36M 1.41M 1.32M
Weighted Average Shares Outstanding (Diluted)
1.52M 9.36M 9.36M 1.41M 1.33M
Currency in USD

Tvardi Therapeutics Earnings and Revenue History